2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Colorectal Neoplasms
12
Pain
11
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
7
Agnosia
6
Colonic Neoplasms
5
Cancer Pain
5
Neuralgia
4
Keratosis, Actinic
4
Head and Neck Neoplasms
4
Liver Neoplasms
3
Leiomyoma
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Mucositis
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Cisplatin
76
Radiotherapy
44
Cetuximab
40
pembrolizumab
39
Paclitaxel
34
Carboplatin
33
Docetaxel
30
Fluorouracil
25
Radiotherapy, Intensity-Modulated
23
Nivolumab
18
Drug Therapy
14
Radiation
12
Erlotinib Hydrochloride
9
cemiplimab
8
Magnetic Resonance Spectroscopy
8
Blood Specimen Collection
8
130-nm albumin-bound paclitaxel
8
durvalumab
7
atezolizumab
7
Cyclophosphamide
7
Afatinib
7
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Panitumumab
6
Leucovorin
6
Esophagectomy
6
Chemoradiotherapy
6
fludarabine
5
aldesleukin
5
Radiosurgery
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled